270 related articles for article (PubMed ID: 37733162)
1. Angiotensin Receptor Blockers and Cognition: a Scoping Review.
Zhou Z; Orchard SG; Nelson MR; Fravel MA; Ernst ME
Curr Hypertens Rep; 2024 Jan; 26(1):1-19. PubMed ID: 37733162
[TBL] [Abstract][Full Text] [Related]
2. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
3. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
Royea J; Hamel E
Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT
Cosarderelioglu C; Nidadavolu LS; George CJ; Marx-Rattner R; Powell L; Xue QL; Tian J; Oh ES; Ferrucci L; Dincer P; Bennett DA; Walston JD; Abadir PM
Geroscience; 2023 Feb; 45(1):371-384. PubMed ID: 35969296
[TBL] [Abstract][Full Text] [Related]
5. The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.
Strauss MH; Hall AS
Prog Cardiovasc Dis; 2016; 58(5):473-82. PubMed ID: 26586276
[TBL] [Abstract][Full Text] [Related]
6. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
7. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines.
Alcocer LA; Bryce A; De Padua Brasil D; Lara J; Cortes JM; Quesada D; Rodriguez P
Am J Cardiovasc Drugs; 2023 Nov; 23(6):663-682. PubMed ID: 37668854
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockers and modulation of radiation-induced brain injury.
Robbins ME; Zhao W; Garcia-Espinosa MA; Diz DI
Curr Drug Targets; 2010 Nov; 11(11):1413-22. PubMed ID: 20583976
[TBL] [Abstract][Full Text] [Related]
9. Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?
Ferrario CM; Saha A; VonCannon JL; Meredith WJ; Ahmad S
Curr Hypertens Rep; 2022 Dec; 24(12):709-721. PubMed ID: 36272015
[TBL] [Abstract][Full Text] [Related]
10. The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review.
Gathiram P; Mackraj I; Moodley J
Curr Hypertens Rep; 2021 Mar; 23(4):17. PubMed ID: 33768439
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin II receptor blockers: current status and future prospects].
Corvol P; Plouin PF
Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
[TBL] [Abstract][Full Text] [Related]
12. Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.
Lévy BI; Mourad JJ
Am J Hypertens; 2022 Apr; 35(4):293-302. PubMed ID: 34265036
[TBL] [Abstract][Full Text] [Related]
13. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.
Ouk M; Wu CY; Rabin JS; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W;
Neurobiol Aging; 2021 Apr; 100():22-31. PubMed ID: 33461049
[TBL] [Abstract][Full Text] [Related]
14. Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis.
Scotti L; Bassi L; Soranna D; Verde F; Silani V; Torsello A; Parati G; Zambon A
Pharmacol Res; 2021 Apr; 166():105515. PubMed ID: 33636351
[TBL] [Abstract][Full Text] [Related]
15. The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Al-Qahtani Z; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Ali NH; Alexiou A; Papadakis M; Saad HM; Batiha GE
J Cell Mol Med; 2024 Jun; 28(12):e18495. PubMed ID: 38899551
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy.
Clark CR; Khalil RA
Biochem Pharmacol; 2024 Feb; 220():115963. PubMed ID: 38061417
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes.
Silva MG; Falcoff NL; Corradi GR; Alfie J; Seguel RF; Tabaj GC; Iglesias LI; Nuñez M; Guman GR; Gironacci MM
Life Sci; 2022 Mar; 293():120324. PubMed ID: 35032553
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
[TBL] [Abstract][Full Text] [Related]
20. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
